[go: up one dir, main page]

PL2225228T3 - Sposób otrzymywania 4-n-furfurylocytozyny i/lub jej pochodnych, kompozycja przeciwstarzeniowa oraz zastosowanie 4-n-furfurylocytozyny i/lub jej pochodnych do wytwarzania kompozycji przeciwstarzeniowej - Google Patents

Sposób otrzymywania 4-n-furfurylocytozyny i/lub jej pochodnych, kompozycja przeciwstarzeniowa oraz zastosowanie 4-n-furfurylocytozyny i/lub jej pochodnych do wytwarzania kompozycji przeciwstarzeniowej

Info

Publication number
PL2225228T3
PL2225228T3 PL08851400T PL08851400T PL2225228T3 PL 2225228 T3 PL2225228 T3 PL 2225228T3 PL 08851400 T PL08851400 T PL 08851400T PL 08851400 T PL08851400 T PL 08851400T PL 2225228 T3 PL2225228 T3 PL 2225228T3
Authority
PL
Poland
Prior art keywords
furfurylcytosine
derivatives
aging composition
manufacture
obtaining
Prior art date
Application number
PL08851400T
Other languages
English (en)
Inventor
Jan Barciszewski
Wojciech T Markiewicz
Eliza Wyszko
Maria Markiewicz
Monika Nowak
Katarzyna Rolle
Ewelina Adamska
Marcin K Chmielewski
Original Assignee
Inst Chemii Bioorganicznej Pan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Chemii Bioorganicznej Pan filed Critical Inst Chemii Bioorganicznej Pan
Publication of PL2225228T3 publication Critical patent/PL2225228T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Cosmetics (AREA)
PL08851400T 2007-11-25 2008-11-25 Sposób otrzymywania 4-n-furfurylocytozyny i/lub jej pochodnych, kompozycja przeciwstarzeniowa oraz zastosowanie 4-n-furfurylocytozyny i/lub jej pochodnych do wytwarzania kompozycji przeciwstarzeniowej PL2225228T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PL383867A PL216370B1 (pl) 2007-11-25 2007-11-25 Sposób otrzymywania 4-N-furfurylocytozyny, kompozycja antystarzeniowa oraz zastosowanie 4-N-furfurylocytozyny do wytwarzania kompozycji antystarzeniowej
PCT/PL2008/000089 WO2009067035A2 (en) 2007-11-25 2008-11-25 Method of obtaining of 4-n-furfurylcytosine and/or its derivatives, an anti-aging composition and use of 4-n-furfurylcytosine and/or its derivatives in the manufacture of anti-aging composition
EP08851400.5A EP2225228B1 (en) 2007-11-25 2008-11-25 Method of obtaining of 4-n-furfurylcytosine and/or its derivatives, an anti-aging composition and use of 4-n-furfurylcytosine and/or its derivatives in the manufacture of anti-aging composition

Publications (1)

Publication Number Publication Date
PL2225228T3 true PL2225228T3 (pl) 2017-10-31

Family

ID=40568369

Family Applications (2)

Application Number Title Priority Date Filing Date
PL383867A PL216370B1 (pl) 2007-11-25 2007-11-25 Sposób otrzymywania 4-N-furfurylocytozyny, kompozycja antystarzeniowa oraz zastosowanie 4-N-furfurylocytozyny do wytwarzania kompozycji antystarzeniowej
PL08851400T PL2225228T3 (pl) 2007-11-25 2008-11-25 Sposób otrzymywania 4-n-furfurylocytozyny i/lub jej pochodnych, kompozycja przeciwstarzeniowa oraz zastosowanie 4-n-furfurylocytozyny i/lub jej pochodnych do wytwarzania kompozycji przeciwstarzeniowej

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL383867A PL216370B1 (pl) 2007-11-25 2007-11-25 Sposób otrzymywania 4-N-furfurylocytozyny, kompozycja antystarzeniowa oraz zastosowanie 4-N-furfurylocytozyny do wytwarzania kompozycji antystarzeniowej

Country Status (6)

Country Link
US (1) US8404660B2 (pl)
EP (1) EP2225228B1 (pl)
DK (1) DK2225228T3 (pl)
ES (1) ES2610209T3 (pl)
PL (2) PL216370B1 (pl)
WO (1) WO2009067035A2 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL229581B1 (pl) * 2010-03-19 2018-08-31 Inst Chemii Bioorganicznej Polskiej Akademii Nauk Analog cytozyny i jego zastosowanie w leczeniu chorób związanych z zaburzeniami metylacji DNA

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU193318B (en) 1985-06-12 1987-09-28 Richter Gedeon Vegyeszet Process for producing new bis- indol derivatives
CA1339503C (en) 1987-02-26 1997-10-21 Suresh I.S. Rattan Method and composition for ameliorating the adverse effects of aging
US5021422A (en) 1989-06-08 1991-06-04 Senetek Plc Method and composition for treating hyperproliferative skin diseases using 6-aminopurine cytokinins
US5164394A (en) 1989-06-08 1992-11-17 Senetek, Plc Method for treating hyperproliferative skin diseases
JP2000319184A (ja) 1991-05-16 2000-11-21 Senetek Plc 皮膚の美的外観を改善するための方法
US5151425A (en) 1991-06-20 1992-09-29 Clark Lealand L Method of and composition for treating inflammation and the immunological response thereto
DE4323615A1 (de) * 1993-07-12 1995-01-19 Schreiner Edelgard Mittel gegen vorzeitiges Altern der Haut
GB9825687D0 (en) 1998-11-25 1999-01-20 Link Technologies Ltd Oligonucleotide conjugation
KR100332031B1 (ko) 1999-06-03 2002-04-10 서경배 피부 주름의 개선 및 생성 억제 효과를 갖는 외용제 조성물
JP2001031549A (ja) 1999-07-14 2001-02-06 Pola Chem Ind Inc 真皮コラーゲン線維束再構築剤及びそれを含有する化粧料
WO2005020885A2 (en) 2003-05-21 2005-03-10 Isis Pharmaceuticals, Inc. Compositions and methods for the treatment of severe acute respiratory syndrome (sars)
JPWO2006080262A1 (ja) 2005-01-27 2008-06-19 学校法人 久留米大学 Age−2アプタマー

Also Published As

Publication number Publication date
PL383867A1 (pl) 2009-06-08
US20100317612A1 (en) 2010-12-16
WO2009067035A3 (en) 2009-09-24
WO2009067035A2 (en) 2009-05-28
US8404660B2 (en) 2013-03-26
EP2225228B1 (en) 2016-10-12
PL216370B1 (pl) 2014-03-31
DK2225228T3 (en) 2017-01-16
ES2610209T3 (es) 2017-04-26
EP2225228A2 (en) 2010-09-08

Similar Documents

Publication Publication Date Title
IL206148A0 (en) Polymeric composition, method for the manufacture of the polymeric composition, articles based on this polymeric composition and use of these articles
IL209188A (en) Sweetener, preparations containing it and methods of manufacture
SG10201605686XA (en) Polishing Composition And Polishing Method Using The Same
EP2340297A4 (en) COMPOSITION, ITS MANUFACTURING METHOD AND USE
IL212836A0 (en) Azaquinolinone derivatives, compositions comprising the same and uses thereof
ZA201003290B (en) Keratin derivatives and methods of making the same
IL212278A0 (en) Morpholinopurine derivatives, compositions comprising the same and uses thereof
GB0709781D0 (en) Composition and method
AP2590A (en) Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
GB0724967D0 (en) Composition and method
IL202677A0 (en) Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
GB0905971D0 (en) Antitussive composition and method for making the same
GB2435262B (en) Method, composition and articles
PL2225228T3 (pl) Sposób otrzymywania 4-n-furfurylocytozyny i/lub jej pochodnych, kompozycja przeciwstarzeniowa oraz zastosowanie 4-n-furfurylocytozyny i/lub jej pochodnych do wytwarzania kompozycji przeciwstarzeniowej
GB0607562D0 (en) Method, composition and use
IL205446A0 (en) Method of preparing (6r) - 3 - hexyl - 4 - hydroxy - 6 - undecyl - 5, 6 - dihydropyran - 2 - one, and intermediate used in the method
IL206951A0 (en) 3-alkyl-piperazine derivatives and uses thereof
PL387749A1 (pl) Nowe pochodne 4,5,6,7-tetrajodobenzimidazolu, sposób ich otrzymywania i zastosowanie medyczne
GB0717401D0 (en) Method and composition
GB0901234D0 (en) Composition,method and use
GB0901293D0 (en) Composition, method and use
GB0901227D0 (en) Composition,method and use
GB0817553D0 (en) Composition and method
GB0816946D0 (en) Composition and method
GB0806334D0 (en) Method and composition